Skip to main content
Future Medicine Co., Ltd. logo

Future Medicine Co., Ltd. — Investor Relations & Filings

Ticker · 341170 ISIN · KR7341170009 KO Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2023-04-27 Report Publication Anno…
Country KR South Korea
Listing KO 341170

About Future Medicine Co., Ltd.

http://futuremedicine.co.kr/

Future Medicine Co., Ltd. is a new drug development company specializing in nucleoside-based synthetic drugs. The company focuses on creating therapeutics for diseases with high unmet medical needs, particularly in antiviral and anticancer applications. Its primary pipeline candidate, FM101, is an anti-inflammatory and anti-fibrotic agent being investigated for the treatment of conditions such as non-alcoholic steatohepatitis (NASH), diabetic nephropathy, and primary biliary cholangitis (PBC). The company has also conducted research and filed patents for therapeutics related to coronaviruses.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location (online), target audience, and purpose of the meeting. It does not contain the actual presentation slides or the financial results themselves, but rather serves as a notification of an upcoming event. According to the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Regulatory Filing (RNS) or a general announcement, as it does not fit the specific criteria for an Investor Presentation (which would be the slides themselves) or other categories.
2023-04-27 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a capital increase (third-party allocation of paid-in capital). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2023-04-07 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees and advisors, including exercise prices, vesting periods, and valuation methods. Since this document pertains to the issuance of new equity-linked instruments (stock options) which affects the company's capital structure, it falls under the 'Share Issue/Capital Change' category.
2023-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회 결과) for the company Future Medicine. It details the approval of financial statements, election of directors, and other agenda items voted upon during the meeting. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it confirms the outcomes of the shareholder meeting.
2023-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the changes in the board of directors, specifically the reappointment of outside directors. This falls directly under the category of Board/Management Information (MANG).
2023-03-31 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) from a Korean company, Future Medicine, detailing a decision to issue new shares via third-party allocation (유상증자결정). This type of filing is a formal regulatory announcement regarding capital structure changes and share issuance. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2023-03-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.